Celebrity Buddhist monk accused of embezzlement and adultery
Shi Yongxin, the top-ranking monk at China's 1,500-year-old Shaolin Temple, helped build the ancient institution into a sprawling global brand centered on its roots as a birthplace of kung fu. In the process, Shi Yongxin also established himself as one of China's best known religious figures — with his lofty commercial ambitions garnering him the nickname the 'CEO monk.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Revvity (RVTY) Stock Is Falling Today
What Happened? Shares of life sciences company Revvity (NYSE:RVTY) fell 7.6% in the afternoon session after the company lowered its full-year profit forecast, which overshadowed its second-quarter earnings and revenue beat. Despite reporting second-quarter revenue of $720 million and an adjusted earnings per share (EPS) of $1.18, both of which surpassed analyst expectations, investors focused on the weaker outlook. Revvity trimmed its full-year adjusted EPS guidance to a range of $4.85 to $4.95. This revision was driven by multiple headwinds, including a double-digit decline in its diagnostics revenue from China, a key international market. The company also faced shrinking profitability, as both its adjusted operating and gross margins fell compared to the previous year. Management also pointed to potential costs related to tariffs. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Revvity? Access our full analysis report here, it's free. What Is The Market Telling Us Revvity's shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The previous big move we wrote about was 10 days ago when the stock dropped 3.2% as several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like Elevance Health and Humana seeing declines due to an analyst downgrade and a lost lawsuit regarding Medicare bonus payments, respectively. Additionally, some pharmaceutical and biotech companies experienced sharp drops following unfavorable news; for instance, Sarepta Therapeutics plunged after a report indicated another patient death tied to its experimental gene therapy, and GSK's blood cancer drug dosage was voted against by the FDA advisory committee. Broader market sentiment, including concerns about rising costs and inadequate pricing for 2025 plans among health insurers, also contributed to the downward pressure on healthcare equities. Revvity is down 14.7% since the beginning of the year, and at $95.58 per share, it is trading 25.2% below its 52-week high of $127.75 from September 2024. Investors who bought $1,000 worth of Revvity's shares 5 years ago would now be looking at an investment worth $845.92. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
T. Rowe Price Japan Fund's Strategic Moves: Spotlight on Disco Corp
Analyzing the Fund's Second Quarter 2025 N-PORT Filing T. Rowe Price Japan Fund (Trades, Portfolio) recently submitted its N-PORT filing for the second quarter of 2025, offering a glimpse into its strategic investment decisions. The fund is known for its focus on Japanese companies, investing at least 80% of its net assets in a diverse range of industries within Japan. The fund's investment philosophy centers on identifying companies with the potential for sustained, above-average earnings growth. This growth-oriented approach is supported by a global team of investment analysts dedicated to in-depth fundamental research. T. Rowe Price Japan Fund (Trades, Portfolio) seeks to acquire stocks at reasonable prices relative to anticipated earnings, cash flow, or book value, favoring companies with strong market positions, attractive business niches, and stable financials. Warning! GuruFocus has detected 9 Warning Sign with TSE:6758. Summary of New Buy T. Rowe Price Japan Fund (Trades, Portfolio) added a total of 5 stocks, among them: The most significant addition was Disco Corp (TSE:6146), with 12,200 shares, accounting for 1.26% of the portfolio and a total value of 3,600,580 million. The second largest addition to the portfolio was Kitazato Corp (TSE:368A), consisting of 268,600 shares, representing approximately 1.12% of the portfolio, with a total value of 3,190,960. The third largest addition was Park24 Co Ltd (TSE:4666), with 87,700 shares, accounting for 0.39% of the portfolio and a total value of 1,123,230. Key Position Increases T. Rowe Price Japan Fund (Trades, Portfolio) also increased stakes in a total of 17 stocks, among them: The most notable increase was Toyota Motor Corp (TSE:7203), with an additional 146,200 shares, bringing the total to 392,500 shares. This adjustment represents a significant 59.36% increase in share count, a 0.88% impact on the current portfolio, with a total value of 6,774,220. The second largest increase was Yokogawa Electric Corp (TSE:6841), with an additional 71,200 shares, bringing the total to 205,800. This adjustment represents a significant 52.9% increase in share count, with a total value of 5,492,460. Summary of Sold Out T. Rowe Price Japan Fund (Trades, Portfolio) completely exited 5 holdings in the second quarter of 2025, as detailed below: Keyence Corp (TSE:6861): T. Rowe Price Japan Fund (Trades, Portfolio) sold all 5,200 shares, resulting in a -0.79% impact on the portfolio. Shimizu Corp (TSE:1803): T. Rowe Price Japan Fund (Trades, Portfolio) liquidated all 183,500 shares, causing a -0.63% impact on the portfolio. Key Position Reduces T. Rowe Price Japan Fund (Trades, Portfolio) also reduced positions in 54 stocks. The most significant changes include: Reduced Takeda Pharmaceutical Co Ltd (TSE:4502) by 100,500 shares, resulting in a -44.67% decrease in shares and a -1.15% impact on the portfolio. The stock traded at an average price of 4,266.48 during the quarter and has returned 1.22% over the past 3 months and 5.76% year-to-date. Reduced Toyota Industries Corp (TSE:6201) by 25,700 shares, resulting in a -59.22% reduction in shares and a -0.85% impact on the portfolio. The stock traded at an average price of 15,509.9 during the quarter and has returned 23.06% over the past 3 months and 27.83% year-to-date. Portfolio Overview At the second quarter of 2025, T. Rowe Price Japan Fund (Trades, Portfolio)'s portfolio included 76 stocks. The top holdings included 6% in Sony Group Corp (TSE:6758), 5.76% in Mitsubishi UFJ Financial Group Inc (TSE:8306), 4.1% in ITOCHU Corp (TSE:8001), 3.67% in Shin-Etsu Chemical Co Ltd (TSE:4063), and 3.54% in Seven & i Holdings Co Ltd (TSE:3382). The holdings are mainly concentrated in 10 of the 11 industries: Industrials, Financial Services, Technology, Consumer Cyclical, Basic Materials, Healthcare, Communication Services, Consumer Defensive, Energy, and Real Estate. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Sign in to access your portfolio
Bloomberg
23 minutes ago
- Bloomberg
Midyear outlook: Asia-Pacific oil refining
This article was written by Bloomberg Intelligence Senior Industry Analyst Henik Fung and Senior Associate Analyst Chia Chen. It appeared first on the Bloomberg Terminal. Asian oil refiners could face stronger margin headwinds in 2H if demand slumps and crude costs spike. Sluggish China exports and industrial activity as a result of US tariffs could deliver a blow to diesel demand. Meanwhile, the availability of more affordable electric vehicles would accelerate wider adoption, weakening gasoline consumption. Escalating MiddleEast tensions could keep the price of oil higher for longer amid widening risk premiums. All these point to a slump in Asia refining margins. BI Asia-Pacific refining peers traded at 0.8x book value as of June 10, below their 10-year average of 1.1x.
